pharma · Critical Limb Ischemia (CLI) · Sarcoma · DSGN
Lxo Ireland Designated
Lxo Ireland Designated Activity Company
Lxo Ireland Designated is a pharma organization headquartered in CARLSBAD, CA, IE. It trades on NYSE under ticker DSGN. Primary therapeutic focus areas include Critical Limb Ischemia (CLI), Sarcoma, Friedreich Ataxia, HP
CARLSBAD, CA, IE HQ
Public company Type
DSGN · NYSE Ticker
Company details
- Status
- Public
- HQ
- CARLSBAD, CA, IE
- Programs
- 68
- Drugs
- 61
- Patents
- 201
CEA protein antigen plus BCG Vaccine Mix for percutaneous use
Phase 1 · mab · Rectal Cancer
CEA protein antigen plus BCG Vaccine Mix for percutaneous use for Rectal Cancer is a Phase 1 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Internal code IND 009549
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lxo Ireland Designated Activity Company
- Phase
- Phase 1
- Modality
- mab
- Indication
- Rectal Cancer
- Status
- active
- Trials
- 1